1. Home
  2. HURA vs MAMA Comparison

HURA vs MAMA Comparison

Compare HURA & MAMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HURA
  • MAMA
  • Stock Information
  • Founded
  • HURA 2009
  • MAMA 2010
  • Country
  • HURA United States
  • MAMA United States
  • Employees
  • HURA N/A
  • MAMA N/A
  • Industry
  • HURA
  • MAMA Specialty Foods
  • Sector
  • HURA
  • MAMA Consumer Staples
  • Exchange
  • HURA Nasdaq
  • MAMA Nasdaq
  • Market Cap
  • HURA 246.9M
  • MAMA 273.3M
  • IPO Year
  • HURA N/A
  • MAMA N/A
  • Fundamental
  • Price
  • HURA $3.33
  • MAMA $6.29
  • Analyst Decision
  • HURA Strong Buy
  • MAMA Strong Buy
  • Analyst Count
  • HURA 1
  • MAMA 3
  • Target Price
  • HURA $11.00
  • MAMA $10.67
  • AVG Volume (30 Days)
  • HURA 216.5K
  • MAMA 243.8K
  • Earning Date
  • HURA 03-04-2025
  • MAMA 12-16-2024
  • Dividend Yield
  • HURA N/A
  • MAMA N/A
  • EPS Growth
  • HURA N/A
  • MAMA N/A
  • EPS
  • HURA N/A
  • MAMA 0.08
  • Revenue
  • HURA N/A
  • MAMA $116,468,000.00
  • Revenue This Year
  • HURA N/A
  • MAMA $19.28
  • Revenue Next Year
  • HURA N/A
  • MAMA $12.74
  • P/E Ratio
  • HURA N/A
  • MAMA $74.66
  • Revenue Growth
  • HURA N/A
  • MAMA 17.20
  • 52 Week Low
  • HURA $2.84
  • MAMA $4.38
  • 52 Week High
  • HURA $14.60
  • MAMA $9.98
  • Technical
  • Relative Strength Index (RSI)
  • HURA N/A
  • MAMA 30.50
  • Support Level
  • HURA N/A
  • MAMA $6.82
  • Resistance Level
  • HURA N/A
  • MAMA $7.62
  • Average True Range (ATR)
  • HURA 0.00
  • MAMA 0.40
  • MACD
  • HURA 0.00
  • MAMA -0.09
  • Stochastic Oscillator
  • HURA 0.00
  • MAMA 2.56

About HURA TuHURA Biosciences Inc. Common Stock

TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.

About MAMA Mama's Creations Inc.

Mama`s Creations Inc is a marketer and manufacturer of fresh deli-prepared foods, found in over 8,400 grocery, mass, club, and convenience stores nationally. The company's broad product portfolio, born from a rich history in Italian foods, now consists of a variety of high-quality, fresh, clean, and easy-to-prepare foods to address the needs of both consumers and retailers.

Share on Social Networks: